The importance of signaling of CD40/CD40L has been demonstrated in a variety of tumor models, and activation of CD40 affects multiple innate immune cells, providing the promise of harnessing CD40 as a therapeutic target in cancer. The gene discussed is CD40LG; the disease is neoplasm.